Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.

@article{Anderson2012InhaledCD,
  title={Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.},
  author={William J. Anderson and Philip M. Short and Peter Andrew Williamson and Brian J Lipworth},
  journal={Chest},
  year={2012},
  volume={142 6},
  pages={
          1553-1561
        }
}
BACKGROUND International guidelines advocate a standard approach to asthma management for all, despite its heterogeneity. "Personalized" treatment of inflammatory asthma phenotypes confers superior benefits. We wished to evaluate dose response to inhaled corticosteroids (ICSs) in patients with asthma with an elevated fractional exhaled nitric oxide (Feno) phenotype using domiciliary measurements. METHODS We performed a randomized, crossover trial in 21 patients with mild to moderate… CONTINUE READING
BETA
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Current appraisal of single inhaler triple therapy in COPD

  • International journal of chronic obstructive pulmonary disease
  • 2018
VIEW 3 EXCERPTS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma?

  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2012

Serial lung function variability using four portable logging meters.

  • The Journal of asthma : official journal of the Association for the Care of Asthma
  • 2009

Similar Papers

Loading similar papers…